Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Rottendorf in Tumor Therapy Research Program | Contract Pharma

What are you searching for?

Sign in
Breaking News

Rottendorf in Tumor Therapy Research Program

Will investigate active substances to develop dosage forms

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Rottendorf Pharma GmbH is participating in a research project dedicated to a photodynamic tumor therapy. The “Medi-WING” promotion program is supported by the German Ministry of Education and Research (BMBF). Photostabilizers are a new and promising category of substances designed to enhance local effectiveness. The ingested photostabilizers are specifically activated through laser light to destroy cancer cells while minimizing damage to healthy cells.
 
Stefanie Krenzlin of Rottendorf Pharma, together with six public and industrial partners, will investigate suitable active substances for a tumor therapy with the goal of developing innovative dosage forms. After the development phase, Rottendorf will continue to be responsible for the scale-up of the product.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics